Start your treatment today
Remchol for home use
CAVADEX® can only be absorbed into the blood stream when administered as an IV or as an enema.
RemChol delivers CAVADEX® via an enema.
Each tube contains CAVADEX® with over 25% absorbed into the blood stream with every treatment.
Remchol tubes can be administered as often as twice a day.
Patients using RemChol report :
Reduction of Angina within 2-4 weeks
Significant reduction of plaque within 2-3 months
No side-effects
Available now
CAVADEX
The story and science of Cavadex
Cavadex reverses heart disease
For over 3 years Cavadex has been saving lives and improving the health of people around the world by reversing heart disease and reducing arterial plaque. Heart disease is the number one killer world-wide and Cavadex is the only treatment that rapidly reduces arterial plaque.
How can we make these claims and where is the science that proves this?
Let me show you......
1. What is Cavadex and how does it reverse heart disease?
Cavadex is a ring-shaped starch (cyclodextrin) that circulates around the vascular system absorbing cholesterol from arterial walls and leaves the body intact with the cholesterol inside it via urine. The cholesterol is sucked out of the arterial plaque and is transported to the kidney’s where the Cavadex (cyclodextrin) containing the cholesterol is excreted via the urine.Cavadex is not metabolized in the body and has no known side effects.
2. What are the benefits of Cavadex?
Customers using Cavadex report:
- Angina starts reducing within weeks.
- Reduction in leg cramps when walking.
- Reduced calcium scores.
- Plaque reduction within months.
- Increased memory ability.
- More energy.
Cavadex requires no lifestyle changes to be effective.
3. How do you get Cavadex into the blood stream?
The Cavadex cyclodextrin if taken orally is broken down in the stomach and isn’t absorbed into the blood stream intact.
Cholrem has developed an enema that allows absorption via the rectum. This is the only way of absorption besides intravenous injection which is costly and not practical.
Remchol enema tubes contain Cavadex
and can be safely self-administered at home.
Remchol box of 32 tubes
4. How do we know Cavadex works?
USA cardiologist Dr. James Roberts MD FACC FAARFM
USA cardiologist Dr. Roberts has been treating his patients for almost 2 years. This is what he has to say about Cavadex.....
"Now that we have Cavadex we can directly remove the plaque"
"Cavadex is directly reversing the arterial disease"
"Cavadex is a universal antidote to atherosclerosis"
"Our patients get better in 2 weeks with Cavadex"
"Rapid onset of biochemical benefit"
"Slow but steady reduction in plaque volume"
"Cavadex improves lower extremity and brain blood flow"
"Cavadex is incredibly safe, you can’t hurt anyone with Cavadex"
Australian Professor Laurie Howes MB BS PhD FRACP FCSANZ
Australian Professor Laurie Howes, head of cardiovascular research at one of Australia’s largest hospitals. Preeminent Consultant Physician (Cardiology) Professor of Pharmacology and Therapeutics at two of Australia’s leading universities This is what he has to say about Cavadex.....
“Cavadex reduces arterial plaque”
"Improving vascular inflammation"
"Cavadex has more safety data than statins when they were introduced"
"Cavadex is one of the greatest medical breakthroughs of our time"
"This is the greatest advance we have had in cardiovascular pharmacology for the treatment of atheroma plaques since statins"
5. What science supports these claims?
Cholrem development of Cavadex timeline
2013
5a. We know HP-B-CD is safe to use on humans....
A human trial was conducted on twin girls suffering from Niemann-Pick disease.
High dose HP-B-CD was administered via IV for over 2 years to remove cholesterol from cells.
Effects of cyclodextrin in two patients with Niemann–Pick Type C disease
https://www.sciencedirect.com/science/article/abs/pii/S10967192120041552016
5b. We know HP-B-CD removes arterial plaque from mice....
Scientists from Bonn university, Germany, trialed HP-B-CD on mice with atherosclerosis
and discovered that HP-B-CD substantially reduced the atherosclerotic plaque.
Cyclodextrin promotes atherosclerosis regression via macrophage reprogramming
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4878149/2019
5c. We know HP-B-CD reduces arterial plaque from humans....
After concluding that the science behind HP-B-CD showed that it was safe on humans and HP-B-CD successfully
reduced arterial plaque in mice, Kyle Hodgetts established the company Cholrem Pty Ltd and did
a trial on himself using HP-B-CD to reduce his arterial plaque, resulting in substantial plaque reduction.
2-hydroxypropyl-β-cyclodextrin reduces atherosclerotic plaques in human coronary artery
Paper currently under review for publishing in medical journal
2021
5d. We know Cavadex reduces arterial plaque and improves lipid profile and liver function....
After the success of the first trial, Cholrem Pty Ltd developed a version of HP-B-CD “CAVADEX” and Kyle did a second trial on himself using Cavadex,
resulting in substantial lipid reduction, improved liver function and reduced arterial plaque.
Kyle consulted with Australian Professor Laurie Howes MB BS PhD FRACP FCSANZ (Head of cardiovascular research at one of Australia’s
largest hospitals. Preeminent Consultant Physician (Cardiology) Professor of Pharmacology and Therapeutics at two of Australia’s leading
universities) and the trial results were confirmed.
Second trial data
Paper currently being written to be published in a medical journal5e. We know Cavadex is absorbed into the blood stream when administered as an enema....
Cholrem Pty Ltd developed an enema version of Cavadex for home use.
The Remchol enema could supply a 25% absorption rate of Cavadex.
Cholrem Pty Ltd established an online store to commence limited sales of Remchol tubes containing Cavadex.
2022
5f. Cardiologists agree with the science and start treating themselves....
USA cardiologist Dr. James Roberts MD FACC FAARFM trialed Cavadex on himself with similar results.
He then went on and supplied his patients with Remchol tubes.
2023
5g. Patients around the world are reversing their heart disease with Cavadex....
Dr. Roberts reports all patients getting better and that Remchol-Cavadex reduced arterial plaque in his
patients without any adverse side-effects. He also reported several other benefits for stroke patients and brain fog.
Dr. Roberts published his data on his website
http://heartfixer.com/Cyclodextrin.htmProfessor Laurie Howes reviews all the available data and writes a paper
Laurie Letter5i. Patients start sharing their stories....
Cholrem Pty Ltd establishes the Facebook Cavadex club where customers using Remchol-Cavadex can report their experience and results.
It becomes clear that everyone benefits from Remchol-Cavadex and no adverse side-effects are reported
except some loose stools and very few reports of stomach cramps.
These side effects are concluded to be from the fact that they are using an enema and not from the Cavadex.
https://www.facebook.com/groups/cholremcavadex
2024
5j. Professor Howes puts his name and reputation behind Cavadex....
Prof. Laurie Howes writes a report about Cavadex.
"It will be the greatest therapeutic advance in cardiovascular medicine since the introduction of the statins."
5l. The world is finding out that Cavadex works and saves lives....
By July Cholrem has shipped out a total of 12,000 boxes totaling 6,000 orders.
5m. We know Cavadex works because big pharma is now trying to shut us down....
On July 11th FDA issues a warning letter to stop marketing Cavadex
FDA warning letter
Is HP-B-CD safe?
Cyclodextrins are approved by the FDA for various applications.
Is HP-B-CD FDA approved for the treatment of heart disease?
Cavadex and HP-B-CD are not recognized by the FDA as a treatment for heart disease.
We have not applied to the FDA for approval, we are not big pharma and don’t have the resources to submit such an application.
Why isn’t anyone else developing HP-B-CD as a treatment for heart disease?
When Eicke Latz (the lead scientists that discovered that HP-B-CD reduced arterial plaque in mice in 2016)
was asked if they would commence clinical trials on humans, replied..
“Latz estimates it will take approximately EUR 1 million to do the trials. One potential drawback is also one of the
most positive aspects of cyclodextrin: the substance, which is a type of sugar, has already been approved by
the US Food and Drug Administration for use in humans. But because it has been in existence for some time,
it cannot be patented. That makes it harder to get a drug company interested in developing cyclodextrin
to treat heart disease, but it also will make it easier to get the drug approved to treat heart disease if
the clinic trials support the research findings.”
From the founder of Cholrem
“I have a moral responsibility and some would argue legal responsibility to continue to provide our
life saving treatment to our fellow man. The science clearly shows that Cavadex is safe and effective in
reducing arterial plaque and reducing the effect of heart disease.
I, in good conscience cannot and will not keep this treatment hidden from mankind.
My hope is for the FDA, in a worse case scenario, leave me to continue on,
or in a best case scenario, please help with assistance or guidance to get this treatment to the main stream."
Why did I find the cure for heart disease?
Because I looked for it.
Why haven't the big pharmaceutical companies found the cure for heart disease?
Were they even looking?
Kyle Hodgetts, Cholrem CEO
Kyle Hodgetts, inventor of Cavadex
The story of how Cholrem was created
Kyle tells the story of how he discovered cyclodextrin, then over 5 years developed CAVADEX and RemChol to treat Heart Disease
This is Kyle's story
Patients are getting better
Douw has been using RemChol for 18 months.
No more need for by-pass surgery
What are customers saying.....
This is a MUST see testimonial
RemChol patient
Helga's calcium score went down.
RemChol lowers calcium score within weeks
Helga had a calcium score test and it was very high
After just 9 weeks using RemChol her score
dropped from 591 down to 521
This 4 minute video could save your life
Heart disease and treatment explained.
Breakthrough Discovery reverses Heart Disease
In 2016 a team of scientists from Germany's Bonn University discovered
a new compound that reduced plaque in mice by over 40% in as little as 4 weeks.
The new cyclodextrin compound (CAVADEX®) was also tested on human plaque and they discovered it affected the plaque in a similar way.
After years of research, our RemChol tubes deliver 2 grams of CAVADEX®
Angina dramatically reduced in 30 days. No diets or exercise.
Read the science
Cholrem is a world leader in the treatment of Heart Disease.
RemChol patient
Howard has been using RemChol for 2 months.
No lifestyle changes
Howard was refused stents by his doctors because he was a heavy smoker and drinker.
After just 2 months on RemChol his condition improved dramatically without any lifestyle changes.
Our Trial Data
APRIL 2019 : CHOLREM PTY LTD LEADS THE WORLD IN RESEARCH
Angiogram: First patient has plaque reduction in just 4 weeks
CAVADEX® was administered to our first patient at our Melbourne clinic in April 2019 and within 4 weeks the plaque was reduced.
CAVADEX® circulates around the cardiovascular system removing built up cholesterol and plaque resulting in significant plaque reduction.
CAVADEX® is absorbed via intravenous application or as an enema only. If taken orally it is destroyed in the gut and has no effect.
Regular low doses of CAVADEX® can have a significant effect on plaque build up over time.
Cyclodextrin has shown to extend lifespan by almost 10% in mice
Mice treated with cyclodextrin showed higher neurological scores than compared with the mice given saline only..
Mice on cyclodextrin lived 10% longer.
Cyclodextrin clears the vascular system and can extend lifespan.
In 2014 at the University of Texas Southwest Medical Center, a study was conducted on the effects of Cyclodextrin administered to mice.
They studied the lifespan of mice treated systemically with either saline or Cyclodextrin at weekly
intervals starting at 49 days of age until death. In each case, half of the males and females were
given Cyclodextrin and the remaining mice received only saline.
During the study, the mice were graded on their neurological function. There were no gender related differences in the neurological scores. This score, which broadly measures neurological
function, declines as the animal’s condition deteriorates.
It is clear that Cyclodextrin treated mice showed higher neurological scores than compared with
the mice given saline only.
All the mice given saline only had died by 98 days whereas the majority of those receiving
Cyclodextrin died in the week following. This shows an almost 10% improvement in lifespan.
More Science
Science Articles
Nature
Cyclodextrin reprogrammed the cells in plaques, leading to increased transport of the dissolved cholesterol away from the plaques...
Science Daily
Cyclodextrin dissolves cholesterol crystals and reduces atherosclerotic plaques...
Huffington Post
can actually solubilize cholesterol and dissolve the plaques...
Science Daily
Soaked up cholesterol and removed it...
Norwegian University of Science and Technology
have the potential in lowering deaths caused by atherosclerosis...
CAVADEX® (cyclodextrin) removes plaque and cholesterol
plaque reduced in just 4 weeks
A recent study by the University Hospital in Bonn, Germany discovered that cyclodextrin melts away cholesterol crystals (the main cause of arterial plaque that clogs arteries) and reduced existing plaque within just 4 weeks. The cyclodextrin bound to and dissolved the cholesterol crystals from the plaque of mice, leading to transport of the dissolved cholesterol away from the plaques. The same effects were seen in human plaque samples treated with cyclodextrin.
Article : Cyclodextrin promotes atherosclerosis regression via macrophage reprogrammingImprove Liver function
Another study by the University of Texas Southwestern Medical Center, Dallas, Texas, shows the treatment of Npc1-deficient mice slows cholesterol sequestration in major organs and improves liver function. This study shows that cyclodextrin is effective in mobilizing entrapped cholesterol in late stage NPC disease leading to improved liver function.
Article : Systemic administration of 2-hydroxypropyl-B-cyclodextrin to symptomatic Npc1-deficient mice slows cholesterol sequestration in the major organs and improves liver function.